Open AccessMetabolic Syndrome and Risk of Restenosis in Patients Undergoing Percutaneous Coronary Intervention
Author(s) -
Jamal S. Rana,
Pascalle S. Monraats,
Aeilko H. Zwinderman,
Moniek P.M. de Maat,
John J.P. Kastelein,
Pieter A. Doevendans,
Robbert J. de Winter,
René A. Tio,
Rune R. Frants,
Arnoud van der Laarse,
Ernst E. van der Wall,
J. Wouter Jukema
Publication year - 2005
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/diacare.28.4.873
Subject(s) - medicine , percutaneous coronary intervention , restenosis , diabetes mellitus , cardiology , metabolic syndrome , myocardial infarction , endocrinology , stent
Patients with metabolic syndrome have increased risk of cardiovascular events. The number of patients with metabolic syndrome is rapidly increasing, and these patients often need revascularization. However, only limited data are available on the effect of metabolic syndrome on restenosis in patients undergoing percutaneous coronary intervention (PCI).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom